Qube Research & Technologies (QRT)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Qube Research & Technologies (QRT)'s LKFT Position: Q3 2026 in Review
Qube Research & Technologies (QRT) opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 65,896 shares worth $1.95M. The stake represents ﹤0.01% of the portfolio and ranks #2334 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in LKFT as recently as Q2 2020.
Qube Research & Technologies (QRT) first reported a position in LKFT in Q1 2018 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Qube Research & Technologies (QRT) held 65,896 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.95M as of Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Qube Research & Technologies (QRT) position in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2334 holding.
- Qube Research & Technologies (QRT) first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and has held it in 5 quarters since.
- 66 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.